Our core is staffed by experts in immunohistochemistry (IHC), in situ hybridization (ISH), and multiplex fluorescence using multiple antibodies and/or probes. We offer routine protocols in these ...

The development of many different chromogens for light microscopy gives us the opportunity to explore different usage of multiplex immunohistochemistry (IHC) for clinical diagnostic purposes as well ...

HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ultivue today unveiled the expanded capabilities of its proprietary InSituPlex® DNA-barcoding and staining technology through comprehensive visualization of a whole ...

The prognostic value of Sprouty2 protein in nonsmall cell lung cancer. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does not include a full text component.

Multiplex immunofluorescence is transforming how scientists visualize complex tissue biology, enabling simultaneous detection of multiple biomarkers with vivid clarity. Achieving these results ...

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced the launch of its SignalStar Multiplex IHC ...

PLEASANTON, Calif.--(BUSINESS WIRE)--Diagnostic Biosystems (DBS), a specialty Immunohistochemistry company, announces its debut as an automated IHC company, introducing the Mosaic 360™ System with a ...

Multiplex immunohistochemistry (IHC) technologies are powerful tools to visualize multiple markers in the same tissue sample. These techniques, which include tyramide signal amplification and cyclic ...